Results 161 to 170 of about 317,693 (354)

Familial Pick's disease and dementia in frontal lobe degeneration of non-Alzheimer type are not variants of prion disease. [PDF]

, 1994
John Collinge, Mark S. Palmer, Katie Sidle, Sukhvir P. Mahal, Tracy Campbell, Jeremy M. Brown, John Hardy, A. Brun, Lars Gustafson, Egbert Bakker   +9 more
openalex   +1 more source

Review of Coherent Anti‐Stokes Raman Scattering Nonresonant Background Removal and Phase Retrieval Approaches: From Experimental Methods to Deep Learning Algorithms

Advanced Photonics Research, EarlyView.
Coherent anti‐stokes Raman spectroscopy (CARS) enables high‐resolution vibrational imaging, yet non‐resonant background (NRB) distorts spectral fidelity. This review highlights NRB removal methods—from experimental strategies and numerical algorithms to emerging deep learning techniques.
Rajendhar Junjuri, Thomas Bocklitz
wiley   +1 more source

The second international conference on alzheimers disease and related disorders

, 1989

openalex   +1 more source

BOOK REVIEWS: Down Syndrome & Alzheimer Disease (Progress in Clinical and Biological Research Vol. 379). [PDF]

, 1993
William Gibb
openalex   +1 more source

Structure and Electrochemical Properties of ReS2‐LaFeO3 Nanocomposite for Dopamine Sensing

Advanced Sensor Research, EarlyView.
A novel ReS2‐LaFeO3 nanocomposite is developed for sensitive and reliable detection of dopamine (DA), an important neurotransmitter. The material performs well even in complex biological samples, demonstrating strong selectivity and accuracy. These findings highlight its potential for future applications in medical diagnostics and neuroscience research.
Obed Graham Keelson, Rajeev Kumar, Amit Kumar Shringi, Hazel Achieng Ouma, Pooja D. Walimbe, Fei Yan   +5 more
wiley   +1 more source

Ultrasensitive Detection of FKBP12 Using a Synthetic Receptor‐Functionalized QCM Nanoplatform

Advanced Sensor Research, EarlyView.
A reusable nanosensor platform for ultralow FKBP12 detection in physiological fluids is presented. Combining a gold‐coated QCM with a custom‐designed receptor in a self‐assembled monolayer, the device achieves picomolar sensitivity and high selectivity.
Martina Tozzetti, Maria Raffaella Martina, Giacomo Lucchesi, Kristian Vasa, Ahtsham Ishaq, Laura Marsili, Piero Procacci, Stefano Menichetti, Gabriella Caminati   +8 more
wiley   +1 more source

Insulin and Alzheimer disease: type 3 diabetes?

Revista de la Facultad de Medicina, 2007
Alzheimer Disease is a neurodegenerative disease of central nervous system whose incidence will increase in next years. Recent investigations relate alzheimer with insulin signaling defects in neurons. Is alzheimer Disease a type 3 diabetes?
Andrés Jagua Gualdrón, Vladimir Ávila Ávila   +1 more
doaj  

Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease.

, 1991
James F. Flood, John E. Morley, E. Roberts   +2 more
openalex   +1 more source

In Situ Immunodetection of Neuronal Caspase-3 Activation in Alzheimer Disease [PDF]

, 1999
Lee A. Selznick, David M. Holtzman, Byung Hee Han, Murat Gökden, Anu Srinivasan, Eugene M. Johnson, Kevin A. Roth   +6 more
openalex   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source